FAMOTIDINE, CALCIUM CARBONATE, AND MAGNESIUM HYDROXIDE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Famotidine, Calcium Carbonate, And Magnesium Hydroxide, and what generic alternatives are available?
Famotidine, Calcium Carbonate, And Magnesium Hydroxide is a drug marketed by Perrigo R And D and is included in two NDAs.
The generic ingredient in FAMOTIDINE, CALCIUM CARBONATE, AND MAGNESIUM HYDROXIDE is calcium carbonate; famotidine; magnesium hydroxide. There are two hundred and eighty-two drug master file entries for this compound. Twenty-three suppliers are listed for this compound. Additional details are available on the calcium carbonate; famotidine; magnesium hydroxide profile page.
Summary for FAMOTIDINE, CALCIUM CARBONATE, AND MAGNESIUM HYDROXIDE
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 2 |
Finished Product Suppliers / Packagers: | 18 |
Formulation / Manufacturing: | see details |
DailyMed Link: | FAMOTIDINE, CALCIUM CARBONATE, AND MAGNESIUM HYDROXIDE at DailyMed |
Pharmacology for FAMOTIDINE, CALCIUM CARBONATE, AND MAGNESIUM HYDROXIDE
Anatomical Therapeutic Chemical (ATC) Classes for FAMOTIDINE, CALCIUM CARBONATE, AND MAGNESIUM HYDROXIDE
US Patents and Regulatory Information for FAMOTIDINE, CALCIUM CARBONATE, AND MAGNESIUM HYDROXIDE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Perrigo R And D | FAMOTIDINE, CALCIUM CARBONATE, AND MAGNESIUM HYDROXIDE | calcium carbonate; famotidine; magnesium hydroxide | TABLET, CHEWABLE;ORAL | 077355-001 | Feb 6, 2008 | OTC | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Perrigo R And D | FAMOTIDINE, CALCIUM CARBONATE, AND MAGNESIUM HYDROXIDE | calcium carbonate; famotidine; magnesium hydroxide | TABLET, CHEWABLE;ORAL | 204782-001 | Aug 29, 2016 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |